Evidence map›Paper›PMID 31073665›Full record

ArticleJournal of biomolecular NMR2019

Identification of conformation-selective nanobodies against the membrane protein insertase BamA by an integrated structural biology approach.

Hundeep Kaur, Jean-Baptiste Hartmann, Roman P Jakob, Michael Zahn, Iwan Zimmermann, Timm Maier, Markus A Seeger, Sebastian Hiller

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biomolecular NMR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Resurfacing promotes antibacterial activity of a lipid A-binding nanobody.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Methods for Engineering Binders to Multi-Pass Membrane Proteins.Bioengineering (Basel, Switzerland) · 2023
    Review
  8. Drug Binding to BamA Targets Its Lateral Gate.The journal of physical chemistry. B · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Allosteric inhibition of LRRK2, where are we now.Biochemical Society transactions · 2020
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hundeep KaurBiozentrum, University of Basel, 4056, Basel, Switzerland.
Jean-Baptiste HartmannBiozentrum, University of Basel, 4056, Basel, Switzerland.
Roman P JakobBiozentrum, University of Basel, 4056, Basel, Switzerland.
Michael ZahnBiozentrum, University of Basel, 4056, Basel, Switzerland.
Iwan ZimmermannInstitute of Medical Microbiology, University of Zurich, 8006, Zurich, Switzerland.
Timm MaierBiozentrum, University of Basel, 4056, Basel, Switzerland.
Markus A SeegerInstitute of Medical Microbiology, University of Zurich, 8006, Zurich, Switzerland.
Sebastian HillerBiozentrum, University of Basel, 4056, Basel, Switzerland. sebastian.hiller@unibas.ch.ORCID http://orcid.org/0000-0002-6709-4684

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PP00P3_144823Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CH) 407240_167125Universität Zürich (CH) BIOEF-17-002
6 · The paper itself

Abstract

The insertase BamA is an essential protein of the bacterial outer membrane. Its 16-stranded transmembrane β-barrel contains a lateral gate as a key functional element. This gate is formed by the C-terminal half of the last β-strand. The BamA barrel was previously found to sample different conformations in aqueous solution, as well as different gate-open, gate-closed, and collapsed conformations in X-ray crystallography and cryo-electron microscopy structures. Here, we report the successful identification of conformation-selective nanobodies that stabilize BamA in specific conformations. While the initial candidate generation and selection protocol was based on established alpaca immunization and phage display selection procedures, the final selection of nanobodies was enhanced by a solution NMR-based screening step to shortlist the targets for crystallization. In this way, three crystal structures of BamA-nanobody complexes were efficiently obtained, showing two types of nanobodies that indeed stabilized BamA in two different conformations, i.e., with open and closed lateral gate, respectively. Then, by correlating the structural data with high resolution NMR spectra, we could for the first time assign the BamA conformational solution ensemble to defined structural states. The new nanobodies will be valuable tools towards understanding the client insertion mechanism of BamA and towards developing improved antibiotics.

Indexed as

Models, MolecularProtein ConformationBacterial Outer Membrane ProteinsDrug Evaluation, PreclinicalMultiprotein ComplexesNuclear Magnetic Resonance, BiomolecularProtein BindingSingle-Domain AntibodiesSolutionsBacterial Outer Membrane ProteinsMultiprotein ComplexesSingle-Domain AntibodiesSolutionsConformational selectionLipid gateNanobodiesOuter membrane proteinProtein foldingProtein structureSolution NMR spectroscopySpecific bindersX-ray crystallography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.